Mostrar el registro sencillo del ítem
dc.contributor.author | Kissling, E | |
dc.contributor.author | Valenciano, M | |
dc.contributor.author | I-MOVE Case-Control Studies Team | |
dc.contributor.author | Jimenez-Jorge, Silvia | |
dc.contributor.author | Mateo-Ontañon, Salvador de | |
dc.contributor.author | Pozo Sanchez, Francisco | |
dc.contributor.author | Ledesma, Juan | |
dc.contributor.author | Casas Flecha, Inmaculada | |
dc.contributor.author | Larrauri, Amparo | |
dc.date.accessioned | 2023-02-10T10:26:24Z | |
dc.date.available | 2023-02-10T10:26:24Z | |
dc.date.issued | 2011-03-17 | |
dc.identifier.citation | Euro Surveill. 2011 Mar 17;16(11):19818. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/15490 | |
dc.description.abstract | We present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: -7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine. | es_ES |
dc.description.sponsorship | The I-MOVE network has been funded by the European Centre for Disease Prevention and Control (ECDC) since 2007. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | Disease Outbreaks | es_ES |
dc.subject.mesh | Adolescent | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Case-Control Studies | es_ES |
dc.subject.mesh | Child | es_ES |
dc.subject.mesh | Europe | es_ES |
dc.subject.mesh | European Union | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Infant | es_ES |
dc.subject.mesh | Infant, Newborn | es_ES |
dc.subject.mesh | Influenza A Virus, H1N1 Subtype | es_ES |
dc.subject.mesh | Influenza Vaccines | es_ES |
dc.subject.mesh | Influenza, Human | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Middle Aged | es_ES |
dc.subject.mesh | Sentinel Surveillance | es_ES |
dc.subject.mesh | Treatment Outcome | es_ES |
dc.subject.mesh | Vaccination | es_ES |
dc.subject.mesh | Young Adult | es_ES |
dc.title | Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 21435329 | es_ES |
dc.format.volume | 16 | es_ES |
dc.format.number | 11 | es_ES |
dc.format.page | 19818 | es_ES |
dc.identifier.doi | 10.2807/ese.16.11.19818-en | es_ES |
dc.contributor.funder | Unión Europea. European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.2807/ese.16.11.19818-en | es_ES |
dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |